Analysts See $0.01 EPS for US Geothermal (HTM); Balchem (BCPC) Sellers Increased By 31.59% Their Shorts

October 30, 2017 - By Henry Gaston

Analysts expect US Geothermal Inc (NYSEAMERICAN:HTM) to report $0.01 EPS on November, 8.HTM’s profit would be $192,385 giving it 97.50 P/E if the $0.01 EPS is correct. After having $-0.03 EPS previously, US Geothermal Inc’s analysts see -133.33% EPS growth. It closed at $3.9 lastly. It is down 12.72% since October 30, 2016 and is downtrending. It has underperformed by 29.42% the S&P500.

Balchem Corporation (NASDAQ:BCPC) had an increase of 31.59% in short interest. BCPC’s SI was 1.18 million shares in October as released by FINRA. Its up 31.59% from 894,200 shares previously. With 84,200 avg volume, 14 days are for Balchem Corporation (NASDAQ:BCPC)’s short sellers to cover BCPC’s short positions. The SI to Balchem Corporation’s float is 3.75%. It closed at $84.07 lastly. It is down 37.77% since October 30, 2016 and is uptrending. It has outperformed by 21.07% the S&P500.

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The company has market cap of $2.69 billion. The Firm operates in four divisions: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. It has a 43.54 P/E ratio. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems.

Among 2 analysts covering Balchem (NASDAQ:BCPC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Balchem had 3 analyst reports since March 8, 2016 according to SRatingsIntel. The rating was downgraded by Sidoti to “Neutral” on Tuesday, March 8. On Friday, November 4 the stock rating was downgraded by Pivotal Research to “Sell”. Pivotal Research maintained the stock with “Sell” rating in Friday, August 4 report.

Investors sentiment decreased to 1.14 in Q2 2017. Its down 0.02, from 1.16 in 2017Q1. It is negative, as 20 investors sold Balchem Corporation shares while 56 reduced holdings. 24 funds opened positions while 63 raised stakes. 26.48 million shares or 2.22% less from 27.08 million shares in 2017Q1 were reported. Natl Bank Of Montreal Can reported 1,658 shares. Tompkins Fin reported 22 shares. Renaissance Technologies Limited Liability accumulated 38,100 shares. Public Employees Retirement Sys Of Ohio invested in 58,653 shares. New York-based National Bank & Trust Of Ny Mellon has invested 0.01% in Balchem Corporation (NASDAQ:BCPC). Price T Rowe Associate Md holds 13,079 shares. Swiss Bank & Trust invested in 0% or 52,500 shares. 5,945 were reported by Financial Bank. Parametric Assoc Limited Liability Corporation has invested 0% in Balchem Corporation (NASDAQ:BCPC). Commonwealth Equity Service Inc invested 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Piedmont Investment Advsrs Lc holds 6,890 shares. Glenmede Trust Na has invested 0% in Balchem Corporation (NASDAQ:BCPC). 117 are owned by First Interstate Natl Bank. California-based Shelton Management has invested 0.02% in Balchem Corporation (NASDAQ:BCPC). State Board Of Administration Of Florida Retirement Sys holds 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 20,878 shares.